Outlook For Crohn's Disease Improves Thanks To New Therapies
Thursday, October 9, 2008 - 21:35
in Health & Medicine
A study led by Mayo Clinic has found that infliximab (Remicade) administered alone (monotherapy) or in combination with azathioprine is a more effective treatment for patients with moderate to severe Crohn's disease than azathioprine alone.